SEC Company Response from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW) — Feb 6, 2018
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: Feb. 6, 2018 · CIK: 0001130598 · Accession: 0001104659-18-006956
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222374
Letter
Re: Onconova Therapeutics, Inc.
February 6, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, DC 20549
Registration Statement on Form S-1 (File No. 333-222374)
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the referenced offering, hereby concurs in the request by Onconova Therapeutics, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. (Eastern Time), or as soon as practicable thereafter, on February 7, 2018, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.
H.C. WAINWRIGHT & CO., LLC
By:
/s/ Edward D. Silvera
Name:
Edward D. Silvera
Title:
Chief Operating Officer
430 Park Avenue | New York, New York 10022 | 212.356.0500
Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC
Show Raw Text
CORRESP 1 filename1.htm February 6, 2018 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, DC 20549 Re: Onconova Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-222374) Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the referenced offering, hereby concurs in the request by Onconova Therapeutics, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. (Eastern Time), or as soon as practicable thereafter, on February 7, 2018, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering. H.C. WAINWRIGHT & CO., LLC By: /s/ Edward D. Silvera Name: Edward D. Silvera Title: Chief Operating Officer 430 Park Avenue | New York, New York 10022 | 212.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC